Terminal complement complexes in acute poststreptococcal glomerulonephritis
暂无分享,去创建一个
[1] S. Hulton,et al. Mesangiocapillary glomerulonephritis associated with meningococcal meningitis, C3 nephritis factor and persistently low complement C3 and C5 , 1992, Pediatric Nephrology.
[2] H. Abboud. Growth factors and the mesangium. , 1992, Journal of the American Society of Nephrology : JASN.
[3] M. Schönermark,et al. Immune damage to the mesangium: antibody- and complement-mediated stimulation and destruction of mesangial cells. , 1992, Journal of the American Society of Nephrology : JASN.
[4] H. Abboud,et al. Platelet-derived growth factor and mesangial cells. , 1992, Kidney international.
[5] C. Ruef,et al. Interleukin-6: an autocrine regulator of mesangial cell growth. , 1992, Kidney international.
[6] G. Hänsch,et al. Complement in inflammation: induction of nephritides and progress to chronicity. , 1991, International archives of allergy and applied immunology.
[7] R. Wyatt,et al. Plasma terminal complement complexes in acute poststreptococcal glomerulonephritis. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[8] F. Stapleton,et al. Changing perspectives in children hospitalized with poststreptococcal acute glomerulonephritis , 1990, Pediatric Nephrology.
[9] G. Biesecker. The complement SC5b-9 complex mediates cell adhesion through a vitronectin receptor. , 1990, Journal of immunology.
[10] B. Morgan. Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects. , 1989, The Biochemical journal.
[11] K. Preissner,et al. Complement S-protein (vitronectin) is associated with cytolytic membrane-bound C5b-9 complexes. , 1988, Clinical and experimental immunology.
[12] R. Wyatt,et al. Complement profiles in acute post-streptococcal glomerulonephritis , 1988, Pediatric Nephrology.
[13] K. Resch,et al. Activation of glomerular mesangial cells by the terminal membrane attack complex of complement. , 1987, Journal of immunology.
[14] J. Tschopp,et al. Effect of nephritic factor on C3 and on the terminal pathway of complement in vivo and in vitro. , 1986, Clinical and experimental immunology.
[15] H. Rus,et al. Immunohistochemical detection of the terminal C5b-9 complement complex in children with glomerular diseases. , 1986, Clinical and experimental immunology.
[16] A. Michael,et al. Cell populations and membrane attack complex in glomeruli of patients with post-streptococcal glomerulonephritis: identification using monoclonal antibodies by indirect immunofluorescence. , 1984, Clinical immunology and immunopathology.
[17] D. Salant,et al. A new role for complement in experimental membranous nephropathy in rats. , 1980, The Journal of clinical investigation.
[18] W. Kolb,et al. The membrane attack mechanism of complement. Isolation and subunit composition of the C5b-9 complex , 1975, The Journal of experimental medicine.
[19] C. Chantler,et al. Plasma C3 and C4 Concentrations in Management of Glomerulonephritis , 1973, British medical journal.
[20] H. Müller-Eberhard,et al. THE MEMBRANE ATTACK MECHANISM OF COMPLEMENT , 1973, The Journal of experimental medicine.
[21] R. T. ten Bensel,et al. Serial complement component alterations in acute glomerulonephritis and systemic lupus erythematosus. , 1969, Clinical and experimental immunology.
[22] C. West,et al. SERUM LEVELS OF BETA-1C GLOBULIN, A COMPLEMENT COMPONENT, IN THE NEPHRITIDES, LIPOID NEPHROSIS, AND OTHER CONDITIONS. , 1964, The Journal of clinical investigation.
[23] W. Couser,et al. Increased urinary excretion of C5b-9 distinguishes passive Heymann nephritis in the rat. , 1989, Kidney international.
[24] M. Kazatchkine,et al. Immunohistochemical study of complement S protein (Vitronectin) in normal and diseased human kidneys: relationship to neoantigens of the C5b-9 terminal complex. , 1989, Clinical and experimental immunology.
[25] H. Müller-Eberhard. The membrane attack complex of complement. , 1986, Annual review of immunology.